Stay updated with breaking news from Shuttle Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving...
Shuttle Pharma's platform of sensitizers are designed to address the urgent clinical need to improve the outcomes of cancer patients treated with radiation therapy while reducing side...
Share this article Share this article ROCKVILLE, Md., May 20, 2021 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc., (Shuttle Pharma) a clinical stage company developing drugs to improve the treatment of cancer patients undergoing radiation therapy is pleased to announce the addition of Chris Senanayake, PhD as a member of its Board of Directors. Shuttle Pharma believes Dr. Senanayake is uniquely qualified to serve as a board member because of his vast experience and expertise in the pharmaceuticals industries. Dr. Senanayake has more than 30 years of pharmaceutical industry experience...